title: Veltin gel (clindamycin phosphate 1.2% and tretinoin 0.025%).
authors.affiliation: Department of Medicine, Baylor University Medical Center, USA. dra@dermcenter.us
authors.forename: William
authors.initials: W
authors.lastname: Abramovits
authors.forename: Marcial
authors.initials: M
authors.lastname: Oquendo
authors.forename: Aditya K
authors.initials: AK
authors.lastname: Gupta
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002981:Clindamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D020100:Hydrogels; D007641:Keratolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014212:Tretinoin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D004338:Drug Combinations; D020100:Hydrogels; D007641:Keratolytic Agents; C557521:Veltin Gel; D002981:Clindamycin; D014212:Tretinoin